Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study

被引:17
作者
Choquette, A. C.
Bouchard, L.
Houde, A.
Bouchard, C.
Perusse, L.
Vohl, M-C
机构
[1] CHU Laval, Res Ctr, CHUQ, Lipid Res Ctr, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Dept Food Sci & Nutr, Quebec City, PQ G1K 7P4, Canada
[3] INAF, Quebec City, PQ, Canada
[4] Univ Laval, Dept Prevent & Social Med, Div Kinesiol, Quebec City, PQ G1K 7P4, Canada
[5] Pennington Biomed Res Ctr, Baton Rouge, LA USA
关键词
cardiovascular risk factor; metabolic syndrome; obesity; upstream transcription factor 1;
D O I
10.1111/j.1399-0004.2007.00755.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cardiovascular (CVD) risk factors are under the influence of environmental and genetic factors. Human upstream transcription factor 1 gene (USF1) encodes for a transcription factor, which modulates the expression of genes involved in lipid and carbohydrate metabolic pathways. The aim of this study was to test the hypothesis that USF1 gene variants are associated with CVD risk factors in the Quebec Family Study (QFS). USF1 has been sequenced in 20 QFS subjects with high plasma apolipoprotein B100 (APOB) levels (> 1.14 g/l) and small, dense low-density lipoprotein (LDL) particles (>= 250.7 angstrom and <= 255.9 angstrom), as well as in five subjects with larger LDL particles. Ten variants were identified in non-coding regions of USF1. Two of these polymorphisms (intron 7 c.561-100 G > A, and exon 11 c.*187 C > T) as well as the c.-56 A > G polymorphism, were genotyped and analyzed in 760 subjects from QFS. Association studies showed that women with c.561-100 A/A and c.*187 T/T genotypes had more favorable adiposity indices (< 0.04). In summary, significant associations between relatively common USF1 genetic variants and CVD risk factors were observed in French Canadians.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 26 条
[1]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[2]   Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia [J].
Ayyobi, AF ;
Brunzell, JD .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (4A) :27J-33J
[3]   A new DNA sequence assembly program [J].
Bonfield, JK ;
Smith, KF ;
Staden, R .
NUCLEIC ACIDS RESEARCH, 1995, 23 (24) :4992-4999
[4]   Detection of a major gene effect for LDL peak particle diameter and association with apolipoprotein H gene haplotype [J].
Bossé, Y ;
Feitosa, MF ;
Després, JP ;
Lamarche, B ;
Rice, T ;
Rao, DC ;
Bouchard, C ;
Pérusse, L ;
Vohl, MC .
ATHEROSCLEROSIS, 2005, 182 (02) :231-239
[5]   Compendium of genome-wide scans of lipid-related phenotypes:: adding a new genome-wide search of apolipoprotein levels [J].
Bossé, Y ;
Chagnon, YC ;
Després, JP ;
Rice, T ;
Rao, DC ;
Bouchard, C ;
Pérusse, L ;
Vohl, MC .
JOURNAL OF LIPID RESEARCH, 2004, 45 (12) :2174-2184
[6]   Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor [J].
Botma, GJ ;
Verhoeven, AJM ;
Jansen, H .
ATHEROSCLEROSIS, 2001, 154 (03) :625-632
[7]  
Bouchard C, 1996, PENN CTR N, V5, P470
[8]   Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver [J].
Casado, M ;
Vallet, VS ;
Kahn, A ;
Vaulont, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) :2009-2013
[9]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[10]  
Connelly PW, 1999, CAN J CARDIOL, V15, P409